Вторичный дефект межпредсердной перегородки у взрослых

Гурьев В.В., Зверев Д.А., Стрелков Д.А., Кучеренко В.С.

Вторичный дефект межпредсердной перегородки (ДМПП) относится к одному из наиболее распространённых врождённых пороков сердца (ВПС), клиническая картина которого обусловлена шунтированием крови между системным и лёгочным кровотоками. Если дефект оставить без коррекции, то с возрастом, существующая объёмная перегрузки сердца, приводит к различным кардиальным осложнениям и ранней, по сравнению со здоровыми людьми, смертности. Транскатетерные и хирургические методы коррекции ДМПП показывают схожие результаты, но, тем не менее, транскатетерное закрытие дефекта более предпочтительно, особенно, в группе взрослых и пожилых пациентов. Коррекция дефекта показана всем пациентам с гемодинамически значимым шунтом на уровне межпредсердной перегородки (МПП), вне зависимости от возраста и симптомов, за исключением пациентов с сопутствующей тяжёлой или необратимой лёгочной гипертензией. Клиническая симптоматика и выживаемость находятся в обратной зависимости от возраста пациента, степени лёгочной гипертензии и времени коррекции порока. В статье предложен к рассмотрению алгоритм отбора и ведения взрослых пациентов с вторичным ДМПП.

1. Зиньковский М.Ф. Врожденные пороки сердца / Под ред. А.Ф. Возианова. – Киев; 2010. – С. 226–237.

2. Зорин А.Б., Щукин В.И., Шевченко Ю.Л., Паламарчук Т.В. Пластика перегородок сердца аутоперикардом // Грудная хирургия. – 1978. – № 2. – С. 28–31.

3. Частная хирургия. Учебник для медицинских вузов. / Под ред. члена–корр. РАМН, проф. Ю.Л. Шевченко. – Т. 1. – СПб.: Специальная литература; 1998. – 517 с.

4. Abaci A, Unlu S, Alsancak Y, et al. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta–analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013;82(7):1123–1138. doi: 10.1002/ccd.24875

5. Ayres NA, Miller-Hance W, Fyfe DA, et al. Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2005;18(1):91–98. doi: 10.1016/j.echo.2004.11.004.

6. Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68(1):75–78. doi: 10.1016/S0003-4975(99)00478-6.

7. Billinger M, Zbinden R, Mordasini R, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011;97(23):1932–1937. doi: 10.1136/heartjnl-2011-300436.

8. Buiatti A, Hessling G, Semmler V, Ammar S. Remote magnetic navigation for persistent atrial fibrillation ablation via a retrograde aortic access: an approach for patients after atrial septal defect device closure. Clin Res Cardiol. 2014;103(12): 1028–1030. doi: 10.1007/s00392–014–0747–6.

9. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32(6): 820–826. doi: 10.1136/hrt.32.6.820.

10. Campbell M, Neill C, Suzman S. The prognosis of atrial septal defect. Br Med J. 1957;1(5032):1375–1383. doi: 10.1136/bmj.1.5032.1375.

11. Cordell HJ, Bentham J, Topf A, et al. Genome–wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet. 2013;45(7):822–824. doi: 10.1038/ng.2637.

12. Dell’avvocata F, Rigatelli G, Cardaioli P, Giordan M. Home-made fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension.
J Geriatr Cardiol. 2011;8(2):127–129. doi: 10.3724/SP.J.1263.2011.00127.

13. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115(8):1039–1050. doi: 10.1161/CIRCULATIONAHA.105.592386.

14. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–2957. doi: 10.1093/eurheartj/ehq249.

15. Engelfriet P, Meijboom F, Boersma E, et al. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort.
Int J Cardiol. 2008;126(3):379–385. doi: 10.1016/j.ijcard.2007.04.044.

16. Engelfriet PM, Duffels MG, Möller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart. 2007;93(6):682–687. doi: 10.1136/hrt.2006.098848.

17. Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87(3):310–314. doi: 10.1016/S0002-9149(00)01364-3.

18. Gabriels C, De Meester P, Pasquet A, et al. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol. 2014;176(3):833–840. doi: 10.1016/j.ijcard.2014.08.009.

19. Gatzoulis MA, Freeman MA, Siu SC, et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–846. doi: 10.1056/NEJM199903183401103.

20. Giardini A, Donti A, Formigari R, et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol. 2004;43(10):1886–1891. doi: 10.1016/j.jacc.2003.10.067.

21. Giardini A, Donti A, Sciarra F, et al. Long-term incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults. Int J Cardiol. 2009; 134(1):47–51. doi: 10.1016/j.ijcard.2008.02.003.

22. Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147(2):218–223. doi: 10.1016/j.ahj.2003.10.005.

23. Heller J, Hagège AA, Besse B, et al. “Crochetage”(notch) on R wave in inferior limb leads: a new independent electrocardiographic sign of atrial septal defect. J Am Coll Cardiol. 1996;27(4):877–882. doi: 10.1016/0735-1097(95)00554-4.

24. Hopkins RA, Bert AA, Buchholz B, et al. Surgical patch closure of atrial septal defects. Ann Thorac Surg. 2004;77(6):2144–2149. doi: 10.1016/j.athoracsur. 2003.10.105.

25. Kobayashi J, Yamamoto F, Nakano K, et al. Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation. 1998;98(19 Suppl):II399–402.

26. Konstantinides S, Geibel A, Olschewski M, et al A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995;333(8): 469–473. doi: 10.1056/NEJM199508243330801.

27. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–309. doi: 10.1016/j.jacc.2003.10.030.

28. Lembcke A, Dohmen PM, Dewey M, et al. Multislice computed tomography for preoperative evaluation of right ventricular volumes and function: comparison with magnetic resonance imaging. Ann Thorac Surg. 2005;79(4):1344–1351. doi: 10.1016/j.athoracsur.2004.09.030.

29. Lok SI, Winkens B, Dimopoulos K, et al. Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect. Int J Cardiol. 2010;142(1):44–49. doi: 10.1016/j.ijcard.2008.12.085.

30. Luks AM, Stout K, Swenson ER. Evaluating the safety of high-altitude travel in patients with adult congenital heart disease. Congenit Heart Dis. 2010;5(3):220–232. doi: 10.1111/j.1747-0803.2010.00415.x.

31. Majunke N, Bialkowski J, Wilson N, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol. 2009;103(4):550–554. doi: 10.1016/j.amjcard.2008.10.018.

32. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007; 115(2):163–172. doi: 10.1161/CIRCULATIONAHA.106.627224.

33. Mohan RA, van Engelen K, Stefanovic S, et al. A mutation in the Kozak sequence of GATA4 hampers translation in a family with atrial septal defects. Am J Med Genet A. 2014;164A(11):2732–2738. doi: 10.1002/ajmg.a.36703.

34. Mulder BJ. Not too old to be closed… Neth Heart J. 2010;18(11):520–521. doi: 10.1007/s12471-010-0826-x.

35. Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial–level shunts. Circulation. 2006;114(18):1962–1967.doi: 10.1161/CIRCULATIONAHA.106.664672.

36. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med.
1990;323(24):1645–1650. doi: 10.1056/NEJM199012133232401.

37. Nyboe C, Fenger-Grøn M, Nielsen-Kudsk JE, Hjortdal V. Closure of secundum atrial septal defects in the adult and elderly patients. Eur J Cardiothorac Surg. 2013;43(4):752–757. doi: 10.1093/ejcts/ezs405.

38. Pérez Matos AJ, Planken RN, Bouma BJ, et al. Unroofed coronary sinus newly diagnosed in adult patients after corrected congenital heart disease. Neth Heart J. 2014;22(5):240–245. doi: 10.1007/s12471-014-0533-0.

39. Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):3015–3038. doi: 10.1161/CIRCULATIONAHA.
106.674812.

40. Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv. 2001;53(3):386–391. doi: 10.1002/ccd.1187.

41. Rao PS, Palacios IF, Bach RG, et al. Platypnea–orthodeoxia: Management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv. 2001;54(1):77–82. doi: 10.1002/ccd.1243.

42. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age: a prospective follow-up study of 21–33 years. Eur Heart J. 2003;24(2):190–197. doi: 10.1016/S0195-668X(02)00383-4.

43. Rosas M, Zabal C, Garcia-Montes J, et al. Transcatheter versus surgical closure of secundum atrial septal defect in adults: impact of age at intervention. A concurrent matched comparative study. Congenit Heart Dis. 2007;2(3):148–155. doi: 10.1111/j.1747-0803.2007.00091.x.

44. Saminek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol. 1992;13(3):152–158. doi: 10.1007/BF00793947.

45. Santangeli P, Di Biase L, Burkhardt JD, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8(11):1669–1675. doi: 10.1016/j.hrthm.2011.06.023.

46. John Sutton MG, Tajik AJ, McGoon DC. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation. 1981;64(2):402–409. doi: 10.1161/01.cir.64.2.402.

47. van Riel AC, Schuuring MJ, van Hessen ID, et al. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014;174(2):299–305. doi: 10.1016/j.ijcard.2014.04.072.

48. Wessels MW, Willems PJ. Genetic factors in non–syndromic congenital heart malformations. Clin Genet. 2010;78(2):103–123. doi: 10.1111/j.1399-0004.2010.01435.x.

49. Yap SC, Drenthen W, Meijboom FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593–1601. doi: 10.1111/j.1471-0528.2009.02301.x.